Snakebite Burden: Clinical Trial on COVIP-Plus Vaccine for Snakebite Management in Nigeria

Phase 1

• Conditions: Snakebite envenoming

• Registration Number: PACTR202105682809727
• Lead Sponsor: Africa Centre of Excellence in Phytomedicine Research and Development University of Jos

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-11
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

All adults 18 years and above that volunteer for the study and grant consent will be recruited into the study

Exclusion Criteria

1. Pregnant women
2. Very old persons (>75 years).
3. Highly malnourished adults (BMI <18.5).
4. Those with a history or Family history of intolerance to Mucuna Pruriens seed.
5. Those detected to be suffering from renal and hepatic disease through the examination of the laboratory tests profile.
6. Those undergoing treatment for immunodeficiency and immunosuppressive disorders such as HIV/AIDS and Cancer.
7. Those on immunosuppressive medication such as steroids, radiotherapy and anticancer medications.
8. Women of childbearing age will be screened for pregnancy and will be counseled to avoid pregnancy in the first month of the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified